Protective effect of cavidine on acetic acid-induced murine colitis via regulating antioxidant, cytokine profile and NF-κB signal transduction pathways

Chemico-Biological Interactions

Volumn 239, Issue , 2015, Pages 34-45

  Niu, Xiaofeng ^a   Zhang, Hailin ^a   Li, Weifeng ^a   Wang, Yu ^a   Mu, Qingli ^a   Wang, Xiumei ^a   He, Zehong ^a   Yao, Huan ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

Antioxidant; Cavidine; Nuclear factor (NF) B; Pro inflammatory cytokines; Ulcerative colitis

Indexed keywords

ACETIC ACID; CAVIDINE; CYTOKINE; GLUTATHIONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; MALONALDEHYDE; MYELOPEROXIDASE; PLANT MEDICINAL PRODUCT; SALAZOSULFAPYRIDINE; SUPEROXIDE DISMUTASE; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ANTIOXIDANT; ANTIULCER AGENT; BERBERINE DERIVATIVE; PEROXIDASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ACTIVITY; DRUG EFFECT; DRUG EFFICACY; DRUG POTENCY; ENZYME ACTIVITY; HISTOPATHOLOGY; MALE; MORTALITY; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PROTECTION; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TISSUE LEVEL; ULCERATIVE COLITIS; WEIGHT REDUCTION; ANIMAL; BLOOD; CHEMICALLY INDUCED; COLITIS, ULCERATIVE; COLON; DISEASE MODEL; DRUG EFFECTS; METABOLISM; PATHOLOGY;

MURINAE; MUS;

ACETIC ACID; ANIMALS; ANTI-ULCER AGENTS; ANTIOXIDANTS; BERBERINE ALKALOIDS; COLITIS, ULCERATIVE; COLON; CYTOKINES; DISEASE MODELS, ANIMAL; GLUTATHIONE; INTERLEUKIN-6; MALE; MICE; NF-KAPPA B; PEROXIDASE; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84933532688     PISSN: 00092797     EISSN: 18727786     Source Type: Journal    
DOI: 10.1016/j.cbi.2015.06.026     Document Type: Article

References (43)

1. W.J. Sandborn, and S.R. Targan Biologic therapy of inflammatory bowel disease Gastroenterology 122 2002 1592 1608
2. C. Packey, and R. Sartor Interplay of commensal and pathogenic bacteria, genetic mutations, and immunoregulatory defects in the pathogenesis of inflammatory bowel diseases J. Intern. Med. 263 6 2008 597 606
3. M. Zhang, Y. Long, Y. Sun, Y.K. Wang, Q. Li, H.J. Wu, and Q. Mei Evidence for the complementary and synergistic effects of the three-alkaloid combination regimen containing berberine, hypaconitine and skimmianine on the ulcerative colitis rats induced by trinitrobenzene-sulfonic acid Eur. J. Pharmacol. 651 2011 187 196
4. E. Talero, S. Sanchez-Fidalgo, C.A. de la Lastra, M. Illanes, J.R. Calvo, and V. Motilva Acute and chronic responses associated with adrenomedullin administration in experimental colitis Peptides 29 2008 2001 2012
5. A. Keshavarzian, S. Sedghi, J. Kanofsky, T. List, C. Robinson, C. Ibrahim, and D. Winship Excessive production of reactive oxygen metabolites by inflamed colon: analysis by chemiluminescence probe Gastroenterology 103 1992 177 185
6. M. Tuorkey, and K. Karolin Anti-ulcer activity of curcumin on experimental gastric ulcer in rats and its effect on oxidative stress/antioxidant, IL-6 and enzyme activities Biomed. Environ. Sci. 22 2009 488 495
7. A. Keshavarzian, G. Morgan, S. Sedghi, J.H. Gordon, and M. Doria Role of reactive oxygen metabolites in experimental colitis Gut 31 1990 786 790
8. T. Kishimoto, S. Akira, and T. Taga Interleukin-6 and its receptor: a paradigm for cytokines Science 258 1992 593 597
9. M.F. Neurath, I. Fuss, M. Pasparakis, L. Alexopoulou, S. Haralambous, K.H. Meyer zum Büschenfelde, W. Strober, and G. Kollias Predominant pathogenic role of tumor necrosis factor in experimental colitis in mice Eur. J. Immunol. 27 1997 1743 1750
10. G. Van Loo, R. De Lorenzi, H. Schmidt, M. Huth, A. Mildner, M. Schmidt-Supprian, H. Lassmann, M.R. Prinz, and M. Pasparakis Inhibition of transcription factor NF-κB in the central nervous system ameliorates autoimmune encephalomyelitis in mice Nat. Immunol. 7 2006 954 961
11. P.P. Tak, and G.S. Firestein NF-κB: a key role in inflammatory diseases J. Clin. Invest. 107 2001 7
12. S. Schreiber, S. Nikolaus, and J. Hampe Activation of nuclear factor κB in inflammatory bowel disease Gut 42 1998 477 484
13. M.C. Di Paolo, O.A. Paoluzi, R. Pica, F. Iacopini, P. Crispino, M. Rivera, G. Spera, and P. Paoluzi Sulphasalazine and 5-aminosalicylic acid in long-term treatment of ulcerative colitis: report on tolerance and side-effects Dig. Liver Dis. 33 2001 563 569
14. B. Bressler, J.K. Marshall, C.N. Bernstein, A. Bitton, J. Jones, I. Leontiadis, R. Panaccione, A.H. Steinhart, F. Tse, and B. Feagan Clinical practice guidelines for the medical management of nonhospitalized ulcerative colitis: the Toronto consensus Gastroenterology 148 2015 1035 1058
15. X.F. Niu, W.F. Li, H.B. Xu, X. Liu, T. Fan, and L. Qi Isoquinoline alkaloids from Corydalis impatiens Chem. Nat. Compd. 49 2013 187 189
16. X.F. Niu, H.L. Zhang, W.F. Li, Q.L. Mu, H. Yao, and Y. Wang Anti-inflammatory effects of cavidine in vitro and in vivo, a selective COX-2 inhibitor in LPS-induced peritoneal macrophages of mouse Inflammation 38 2015 923 933
17. D. Rachmilewitz, F. Karmeli, K. Takabayashi, T. Hayashi, L. Leider-Trejo, J. Lee, L. Leoni, and E. Raz Immunostimulatory DNA ameliorates experimental and spontaneous murine colitis Gastroenterology 122 2002 1428 1441
18. A. Jagtap, S. Shirke, and A. Phadke Effect of polyherbal formulation on experimental models of inflammatory bowel diseases J. Ethnopharmacol. 90 2004 195 204
19. J. He, J.R. Liang, S. Zhu, J. Li, Y.M. Zhang, and W.J. Sun Anti-inflammatory effects of Pulvis Fellis Suis extract in mice with ulcerative colitis J. Ethnopharmacol. 138 2011 53 59
20. M.S. Moron, J.W. Depierre, and B. Mannervik Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver Biochim. Biophys. Acta 582 1979 67 78
21. R. Kojima, S. Hamamoto, M. Moriwaki, K. Iwadate, and T. Ohwaki The new experimental ulcerative colitis model in rats induced by subserosal injection of acetic acid Nihon Yakurigaku Zasshi. Folia Pharmacol. Jap. 118 2001 123 130
22. C.O. Elson, R.B. Sartor, G.S. Tennyson, and R.H. Riddell Experimental models of inflammatory bowel disease Gastroenterology 109 1995 1344 1367
23. X.F. Niu, T. Fan, W.F. Li, H.M. Huang, Y.M. Zhang, and W. Xing Protective effect of sanguinarine against acetic acid-induced ulcerative colitis in mice Toxicol. Appl. Pharmacol. 267 2013 256 265
24. S. Sunkara, G. Swanson, C.B. Forsyth, and A. Keshavarzian Chronic inflammation and malignancy in ulcerative colitis Ulcers 2011 2011
25. D. Rachmilewitz, P.L. Simon, L.W. Schwartz, D. Griswold, J.D. Fondacaro, and M.A. Wasserman Inflammatory mediators of colitis in rats Gastroenterology 97 1989 328 337
26. A.R. Martín, I. Villegas, M. Sánchez-Hidalgo, D. La Lastra, and C. Alarcón The effects of resveratrol, a phytoalexin derived from red wines, on chronic inflammation induced in an experimentally induced colitis model Br. J. Pharmacol. 147 2006 873 885
27. A. Higa, T. Eto, and Y. Nawa Evaluation of the role of neutrophils in the pathogenesis of acetic acid-induced colitis in mice Scand. J. Gastroenterol. 32 1997 564 568
28. S.J. Klebanoff Myeloperoxidase: friend and foe J. Leukoc. Biol. 77 2005 598 625
29. K.M. Mullane, R. Kraemer, and B. Smith Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemie myocardium J. Pharmacol. Methods 14 1985 157 167
30. L.A. Kruidenier, and H. Verspaget Oxidative stress as a pathogenic factor in inflammatory bowel disease - radicals or ridiculous? Aliment. Pharmacol. Ther. 16 2002 1997 2015
31. N. Sivalingam, J. Basivireddy, K. Balasubramanian, and M. Jacob Curcumin attenuates indomethacin-induced oxidative stress and mitochondrial dysfunction Arch. Toxicol. 82 2008 471 481
32. S. Danese, and A. Mantovani Inflammatory bowel disease and intestinal cancer: a paradigm of the Yin-Yang interplay between inflammation and cancer Oncogene 29 2010 3313 3323
33. E. Niki Lipid peroxidation: physiological levels and dual biological effects Free Radic. Biol. Med. 47 2009 469 484
34. S. Chavan, L. Sava, V. Saxena, S. Pillai, A. Sontakke, and D. Ingole Reduced glutathione: importance of specimen collection Indian J. Clin. Biochem. 20 2005 150 152
35. B. Sid, J. Verrax, and P.B. Calderon Role of oxidative stress in the pathogenesis of alcohol-induced liver disease Free Radic. Res. 47 2013 894 904
36. N. Kannan, and C. Guruvayoorappan Protective effect of Bauhinia tomentosa on acetic acid induced ulcerative colitis by regulating antioxidant and inflammatory mediators Int. Immunopharmacol. 16 2013 57 66
37. H. Ogata, and T. Hibi Cytokine and anti-cytokine therapies for inflammatory bowel disease Curr. Pharm. Des. 9 2003 1107 1113
38. H. Arab, S. Salama, A. Eid, H. Omar, E. Arafa, and I. Maghrabi Camel's milk ameliorates TNBS-induced colitis in rats via downregulation of inflammatory cytokines and oxidative stress Food Chem. Toxicol. 69 2014 294 302
39. J. Luo, J. Cao, X. Jiang, and H. Cui Effect of low molecular weight heparin rectal suppository on experimental ulcerative colitis in mice Biomed. Pharmacother. 64 2010 441 445
40. J. Mudter, and M.F. Neurath Il-6 signaling in inflammatory bowel disease: pathophysiological role and clinical relevance Inflamm. Bowel Dis. 13 2007 1016 1023
41. K. Sakthivel, and C. Guruvayoorappan Amentoflavone inhibits iNOS, COX-2 expression and modulates cytokine profile, NF-κB signal transduction pathways in rats with ulcerative colitis Int. Immunopharmacol. 17 2013 907 916
42. N.D. Perkins Achieving transcriptional specificity with NF-κB Int. J. Biochem. Cell Biol. 29 1997 1433 1448
43. P.P. Tak, and G.S. Firestein NF-κB: a key role in inflammatory diseases J. Clin. Invest. 107 2001 7 11